Novartis sells US rights to cancer drug Proleukin to Clinigen for up to $210 million httpswww.firstwordpharma.comnode1624954tsid33Â
Novartis sells US rights to cancer drug Proleukin to Clinigen for up to $210 million https://www.firstwordpharma.com/node/1624954?tsid=33 …
More From BioPortfolio on "Novartis sells US rights to cancer drug Proleukin to Clinigen for up to $210 million https://www.firstwordpharma.com/node/1624954?tsid=33 …"